Clinical Trial Update: Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism [EARLY_Phase 1]

View source ↗

Summary

This early-phase Phase 1 trial investigated FXR activation and its effects on hepatic lipid and glucose metabolism in participants with metabolic syndrome and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Combined Hyperlipidemia
• Familial Hypertriglyceridemia
• Metabolic Syndrome

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Metabolic Syndrome, Familial Hypertriglyceridemia | EARLY_Phase 1 | Status: COMPLETED